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Maternal vascular dysfunction is a hallmark of pre-
eclampsia. A recently described vascular phenotype
of preeclampsia involves increased expression of ma-
trix metalloproteinase-1 (MMP-1) in endothelial cells,
vascular smooth muscle, and infiltrating neutrophils.
In contrast, the expression of tissue inhibitor of met-
alloproteinases-1 (TIMP-1) and collagen type I 1 is
either reduced or not changed in the vessels, suggest-
ing an imbalance in vessel collagen degradation and
synthesis in preeclampsia. In the present study, we
explored the possible contribution of DNA methyl-
ation to the altered expression of genes involved in
collagen metabolism. We assayed the differences in
DNA methylation in omental arteries from normal
pregnant and preeclamptic women, and determined
whether reduced DNA methylation increases the ex-
pression of MMP-1 in cultured vascular smooth mus-
cle cells and a neutrophil-like cell line, HL-60. Several
MMP genes, including MMP1 and MMP8, were signif-
icantly less methylated in preeclamptic omental ar-
teries, whereas TIMP and COL genes either were sig-
nificantly more methylated or had no significant
change in their DNA methylation status compared
with normal pregnancy. Experimentally induced
DNA hypomethylation increased MMP-1 expression
in cultured vascular smooth muscle cells and MMP-1
cells. Our findings suggest that epigenetic regulation
contributes to the imbalance in genes involved in colla-
gen metabolism in blood vessels of preeclampticwomen. (Am J Pathol 2012, 181:1455–1463; http://dx.doi.
org/10.1016/j.ajpath.2012.06.019)
Preeclampsia is a multisystemic disorder that is diag-
nosed by new onset of hypertension and proteinuria,
which occur after 20 weeks of gestation in pregnant
women who are otherwise normal.1 It is also associated
with pathological edema due to increased vascular per-
meability. Preeclampsia and its complications are among
the leading causes of obstetrical mortality and morbid-
ity.1 In the United States, preeclampsia occurs in approxi-
mately 6% to 8% of pregnant women, and is estimated to be
responsible for 15% of obstetrical deaths.2 Recently, neu-
trophil infiltration associated with marked inflammation of
maternal systemic blood vessels was reported as a char-
acteristic phenotype in women with preeclampsia3–5
We recently reported that matrix metalloproteinase
(MMP)-1 expression is increased in systemic blood ves-
sels of preeclamptic women compared with normal preg-
nant women.6 The increased expression of MMP-1 in
omental arteries was detected in vascular smooth muscle
cells (VSMCs), endothelial cells, and infiltrating leukocytes.
Plasma levels of MMP-1 were also increased in preeclamp-
tic women. Interestingly, omental arteries collected from
preeclamptic women showed no change in the expression
Supported, in part, by grants from the National Heart, Lung, and Blood
Institute (RO1 HL069851 to S.W.W.); the National Center on Minority
Health and Health Disparities (P60 MD002256 to J.F.S.); the Perinatology
Research Branch, Division of Intramural Research, Eunice Kennedy
Shriver National Institute of Child Health and Human Development, NIH,
Department of Health and Human Services (N01 HD-2-3342 to J.F.S.);
and NIH Fogarty grant (1D43 TW007692 to G.E.-G.). DNA sequencing
and methylation analysis were performed at the Virginia Commonwealth
University Nucleic Acids Research Facility core laboratory, which is sup-
ported, in part, by funding from NIH–National Cancer Institute Cancer
Center Support Grant (P30 CA016059), and the National Center for Ad-
vancing Translational Sciences (CTSA award No. UL1TR000058).
Accepted for publication June 20, 2012.
Address reprint requests to Scott W. Walsh, Ph.D., Department of
Obstetrics and Gynecology, Virginia Commonwealth University Medical
Center, 1101 E Marshall St, PO Box 980034, Richmond, VA 23298-0034.
E-mail: swwalsh@vcu.edu.
1455
1456 Mousa et al
AJP October 2012, Vol. 181, No. 10of tissue inhibitor of metalloproteinases-1 (TIMP-1) and de-
creased expression of collagen type I 1 (COLIA1), which
is the main component of type 1 collagen. Collectively,
these observations suggest an imbalance in vascular col-
lagen metabolism that favors degradation in preeclampsia.
In addition, MMP-1 was a regulator of arterial vessel tone,
implicating this metalloproteinase in the pathogenesis of
systemic hypertension associated with preeclampsia.6
The expression level of several MMP genes, including
MMPs 1, 2, 3, 7, 9, and 14, is regulated by DNA methyl-
ation,7 and MMP-9 has been shown to be regulated by
DNA methylation in placentas of women with preeclamp-
sia.8 DNA hypomethylation induced by 5-aza-2-deoxycy-
tidine (5-Aza) treatment resulted in a significant increase
in MMP-1 expression in cultured amnion fibroblasts.9 The
increase in MMP-1 expression correlated with decreased
DNA methylation at a particular location in the MMP1
promoter 1538 bp upstream from the transcription start
site. DNA methylation at the same site was significantly
reduced in amnion tissues collected from pregnancies
with preterm premature rupture of the fetal membranes.9
This evidence for epigenetic regulation of MMP1, and
other MMP genes, led us to hypothesize that reduced
DNA methylation might contribute to the increased ex-
pression of MMPs in the systemic vasculature of pre-
eclamptic women, leading to the imbalance in genes
involved in collagen metabolism.6 In this study, we ex-
amined DNAmethylation in the promoter regions ofMMP,
TIMP, and COL genes in omental arteries obtained from
normal pregnant and preeclamptic women. We also stud-
ied the effect of DNA hypomethylation on the expression of
MMP-1, TIMP-1, and COLIA1 in primary cultures of human
VSMCs and the expression of MMP-1 and the neutrophil
collagenase, MMP-8, in a neutrophil-like cell line.10 We ex-
amined the effect of hypomethylation in a neutrophil cell line
because of the extensive vascular infiltration of neutrophils
that occurs in women with preeclampsia.3–5
Materials and Methods
Study Subjects
Omental and s.c. fat samples of approximately 2 2 0.5
cm were obtained at cesarean section from normal preg-
Table 1. Clinical Characteristics of Patient Groups
Variable
No
Maternal age (years)
Prepregnancy BMI (kg/m2)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Proteinuria (mg/24 hours)
Dipstick
Parity
Primiparous
Multiparous
Gestational age (weeks)
Infant birth weight (g)
Values are presented as mean  SEM unless otherwise indicated.
*P  0.05, **P  0.001 by t-test.
BMI, body mass index; ND, not determined.nant women (n  18) and women clinically diagnosed ashaving mild or severe preeclampsia (n 21) at the Medical
College of Virginia Hospital, Virginia Commonwealth Univer-
sity Medical Center (Richmond, VA). Mild preeclampsia
was diagnosed when the blood pressure was140 mmHg
systolic or 90 mmHg diastolic and there was 0.3 g of
urinary protein per 24 hours after 20 weeks of gestation.
Severe preeclampsia was diagnosed when the blood pres-
sure was 160 mmHg systolic or 110 mmHg diastolic,
with 5 g of protein in the urine within 24 hours after 20 weeks
of gestation.1 Omental fat arteries were used because they
are a component of the maternal systemic vasculature, and
they play a role in blood pressure regulation by contributing
to the total peripheral vascular resistance. Women with cho-
rioamnionitis, infections, active sexually transmitted dis-
eases, lupus, or diabetes and women who were smokers or
in labor were excluded because these conditions are asso-
ciated with inflammatory changes. Patient clinical data are
shown in Table 1. This study was approved by the Office of
Research Subjects Protection, Virginia Commonwealth Uni-
versity. All subjects gave informed consent.
Sample Processing and Bisulfite Sequencing
Omental arteries from nine normal pregnant women and
nine preeclamptic women (five mild and four severe)
were dissected and cleaned of adhering fat. DNA was
extracted from the arteries (approximately 10 mg by
weight) using a QuickGene DNA tissue kit and a Quick-
Gene-Mini80 system (AutoGen, Holliston, MA). DNA was
treated with RNase A (Qiagen, Valencia, CA). DNA (1 g)
was bisulfite treated using a MethylEasy Exceed kit (Hu-
man Genetic Signatures, Randwick, Australia), and DNA
sequencing was performed as previously described.9
Briefly, 100 ng of bisulfite-treated DNA was PCR ampli-
fied for two rounds using our previously published prim-
ers for the 1538 site in the MMP1 promoter. PCR prod-
ucts were purified with a QIAquick PCR Purification kit
(Qiagen), and 1 L of each product was cloned into pCR
2.1-TOPO vectors using the TOPO TA cloning kit (Invit-
rogen, Carlsbad, CA). After bacteria amplification, eight
cloned PCR segments for each patient were sequenced
in the Nucleic Acids Research Facilities at Virginia Com-
egnant women
 18)
Preeclamptic women
(n  21)
.1  1.3 24.6  1.0
.2  1.2 30.7  1.6*
.1  2.3 166.8  2.4**
8  1.8 93.5  2.6**
ND 286.8  21.6 (n  8)
ND 2.7  0.3 (n  13)
3 15
15 6
.2  0.2 35.4  0.9**
3  100 2452  248**rmal pr
(n
26
26
117
70.1
39
350monwealth University. The 1538 site was selected be-
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correlates with the expression of MMP-1.9
Illumina Infinium HumanMethylation27
BeadChip Assay
Omental arteries from five normal pregnant and seven
severe preeclamptic women were processed for DNA
extraction. DNA was bisulfite treated and used in the
high-throughput Illumina Infinium HumanMethylation27
BeadChip assay (Illumina, San Diego, CA) for global
DNA methylation analysis. The BeadChip was run by the
Nucleic Acids Research Facilities at Virginia Common-
wealth University using the protocol provided by Illumina.
Data analysis was performed using the beadarray pack-
age in the R programming environment.11 Methylation ()
values are expressed as a range from 0 to 1, where 0
means not methylated and 1 means fully methylated.
Differences in methylation between normal pregnant and
preeclamptic women were indicated by  values.
IHC Data
Omental and s.c. fat samples from six normal pregnant and
six preeclamptic women were cut into small pieces, fixed
immediately in 10% neutral-buffered formalin, and embed-
ded in paraffin. Tissues were cut into sections (8 m thick),
which were stained for rabbit anti-human polyclonal anti-
body specific for MMP-8, neutrophil collagenase (1:100
titer; catalog number 17874-1-AP; Proteintech, Chicago,
IL), and mouse monoclonal IgM anti-human CD66b, a
neutrophil antigen (1:50; catalog number 555723; BD
BioSciences, San Diego, CA). Rabbit primary antibody
isotype control (Invitrogen) was used as a negative con-
trol. A kit was used for immunohistochemical (IHC) stain-
ing [SuperPicTure Polymer Detection Kit Broad Spectrum
(diaminobenzidine); Invitrogen]. To quench endogenous
tissue peroxidase activity, slides were incubated in 3%
hydrogen peroxide in methanol for 30 minutes. For anti-
gen retrieval, slides were heat treated in 10 mmol/L ci-
trate buffer for 5 minutes with a pressure cooker. Tissue
slides were counterstained with a 1:5 dilution of Hema-
toxylin QS (Vector Laboratories, Burlingame, CA). Vessel
staining for MMP-8 was evaluated using an intensity scale
ranging from 0 to 4, where 0 was assigned for no staining
and 4 was dark and extensive staining. Scoring was verified
by a second investigator (S.W.W.) and by measuring the
OD of staining using image analysis software (cellSens Im-
aging Software; Olympus America, Center Valley, PA), as
previously described.3,4 The OD of staining for MMP-8 in
vessels was normalized to the OD of the background.
Slides were also analyzed for vessels with diffuse staining
and leukocytes staining for MMP-8. Images were captured
with cellSens Imaging Software.
Human VSMCs
Human VSMCs were cultured from chorionic plate arter-
ies of placentas collected at cesarean section from
healthy pregnant women at term deliveries, as previouslydescribed.12 Cells were cultured in T-25 flasks using
Medium-199 (Gibco, Invitrogen) with 10% fetal bovine
serum (Gibco, Invitrogen), 1% antibiotics, and antimycot-
ics (100 U/mL penicillin, 100 g/mL streptomycin, and 25
g/mL amphotericin B; Gibco, Invitrogen). Cells were
treated with 10 mol/L of 5-Aza (Sigma-Aldrich, St. Louis,
MO), an agent that inhibits DNA methylation when incor-
porated into DNA during cell division,13 for 48 hours.
Treatments were refreshed daily. Cells were 50% conflu-
ent at treatment and nearly 100% confluent at harvesting.
Conditioned media were collected and centrifuged to
remove cell debris. Cells were rinsed in PBS and har-
vested for RNA or protein extraction.
HL-60 Cells
To examine the role of DNA methylation in regulating the
expression of MMP-1 and MMP-8 in neutrophils, it was
necessary to use a neutrophil-like cell line (HL-60) be-
cause neutrophils isolated from patients do not divide
and, therefore, 5-Aza cannot be incorporated into the
genomic DNA to induce hypomethylation. HL-60 cells
(ATCC, Manassas, VA) were cultured in Iscove’s modified
Dulbecco’s medium (ATCC) supplemented with 10% fetal
bovine serum (Gibco, Invitrogen), 1% antibiotics, and anti-
mycotics (100 U/mL penicillin, 100 g/mL streptomycin,
and 25 g/mL amphotericin B; Gibco, Invitrogen), as rec-
ommended by ATCC. Approximately 500,000 cells/mL
were seeded in 5 mL of media in a T-25 flask for treatments.
Cell treatments were as follows: i) 10 mol/L 5-Aza for 48
hours, followed by 108 mol/L of phorbol 12-myristate 13-
acetate (PMA), a protein kinase C activator (Sigma-Aldrich)
for 24 hours; ii) 10 mol/L 5-Aza for 48 hours, followed by no
treatment for 24 hours; iii) no treatment for 48 hours, fol-
lowed by 108 mol/L PMA for 24 hours; or iv) no treatment
for 72 hours to serve as a control. Cells were collected for
RNA and protein extraction.
Quantitative Real-Time PCR
RNA was extracted using a QuickGene RNA cultured cell
kit with a QuickGene Mini-80 system (AutoGen, Holliston,
MA). DNase treatment was performed using a Turbo
DNase kit (Ambion, Austin, TX). RNA (1 g) was reverse
transcribed to cDNA using the iScript cDNA Synthesis Kit
(Bio-Rad Laboratories, Hercules, CA). Quantitative real-
time PCRs were performed with RT2 SYBR Green qPCR
Mastermix (SABiosciences, Frederick, MD), as recom-
mended by the user manual, and 8 ng of cDNA was used
per reaction. GAPDH was used as a housekeeping gene.
Commercial primers were used for the MMP1 and MMP8
genes (SABiosciences). Primers for the GAPDH, TIMP1,
and COLIA1 genes, shown in Table 2, were synthesized
by Integrated DNA Technologies (Coralville, IA). Fold
changes were calculated by the CT method.
Western Blot Analysis
Cells were lysed in radioimmunoprecipitation assay buf-
fer containing 150 mmol/L sodium chloride, 1.0% Nonidet
P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl
C-3=
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protease inhibitor (Thermo Scientific, Pittsburgh, PA) us-
ing a tip sonicator (Active Motif, Carlsbad, CA). Protein
concentrations were measured using the bicinchoninic
acid assay (Thermo Fisher Scientific, Rockford, IL). De-
natured protein lysates (100 g) were resolved by elec-
trophoresis using 10% Tris-glycine SDS-PAGE electro-
transferred to a polyvinylidene fluoride membrane
(Immobilon-FL; Millipore, Billerica, MA). The primary an-
tibodies used were as follows: goat anti-human MMP-1
(0.2 g/mL; R&D Systems, Minneapolis, MN), goat anti-
human COLIA1 (1:1000; Santa Cruz Biotechnology,
Santa Cruz, CA), rabbit anti-human MMP-8 (1:250; Pro-
teintech, Chicago, IL), rabbit anti-human -actin (1:1000;
Sigma-Aldrich), and mouse anti-human -actin (1:1000;
Sigma-Aldrich). Secondary antibodies used included Al-
exa Fluor 680 donkey anti-rabbit (1:20,000; Invitrogen) for
the detection of primary antibodies raised in rabbit for -ac-
tin or MMP-8; IRDye800 donkey anti-goat (1:20,000; Rock-
land Immunochemicals, Gilbertsville, PA) for the detection
of primary antibodies raised in goat for MMP-1 or COLIA1;
and IRDye800 goat anti-mouse (1:20,000; Rockland Immu-
nochemicals) for the detection of primary antibody raised in
mouse for -actin. The LI-COR Odyssey Infrared Imaging
System (Thermo Scientific, Pittsburgh) was used to detect
the immunoreactive proteins.
ELISA
Commercial enzyme-linked immunosorbent assay (ELISA)
kits were used to quantify total MMP-1 (GE Healthcare,
Piscataway, NJ) and TIMP-1 (GE Healthcare) in VSMC cul-
ture medium. For normalization, the total amount of MMP-1
or TIMP-1 protein in 5 mL (volume of medium used in a T-25
Table 2. Quantitative RT-PCR Primers Used for Gene Expression
Gene Forward primer
GAPDH 5=-GATTCCACCCATGGCAAATT-
TIMP1 5=-CTGTGGCTCCCTGGAACA-3=
COL1A1 5=-ACGAAGACATCCCACCAATCA
Table 3. List of COL, MMP, and TIMP Genes that Were Significa
Symbol Name
COL8A1 Collagen, type VIII,  1
COL9A3 Collagen, type IX,  3
COL19A1 Collagen, type XIX,  1
MMP1 Matrix metalloproteinase 1
MMP8 Matrix metalloproteinase 8
MMP12 Matrix metalloproteinase 12
MMP13 Matrix metalloproteinase 13
MMP16 Matrix metalloproteinase 16
MMP21 Matrix metalloproteinase 21
MMP26 Matrix metalloproteinase 26
MMP27 Matrix metalloproteinase 27
TIMP3 Tissue inhibitor of metalloproteinases 3
* indicates methylation values where 0 is no methylation and 1 is fu
indicate less methylation, and positive values indicate more methylation in PE a
NP, normal pregnant; PE, preeclamptic.flask) was divided by the total amount of DNA (g) ex-
tracted from the cells of the same flask.
Statistical Analysis
The Mann-Whitney U-test was used to analyze the data
from bisulfite sequencing and for visual intensity score
data. A Student’s t-test was used to make comparisons of
parameters between two groups, and a one-way analysis
of variance with a Newman-Keuls test was used to make
comparisons of parameters between more than two
groups for normally distributed data. Quantitative results
were presented as mean  SEM. We considered P 
0.05 as statistically significant. A statistical software pro-
gram was used for data analysis (Prism 4 for Macintosh
version 4.0a; GraphPad Software, Inc., San Diego, CA).
Results
The Illumina BeadChip assay revealed a significant de-
crease in DNA methylation in the promoter regions of
MMP1 and MMP8 genes in omental arteries from pre-
eclamptic women compared with normal pregnant
women. However, there were no significant changes in
DNA methylation in the promoter regions of TIMP1 or
COLIA1 genes. Other MMP, TIMP, and COL genes that
were differentially methylated in preeclamptic arteries are
shown in Table 3. All MMP genes, except two, were less
methylated, whereas TIMP and COL genes were, in gen-
eral, relatively more methylated. Bisulfite DNA sequenc-
ing revealed a significant decrease in methylation at the
1538 site in the promoter region of the MMP1 gene in
omental arteries from women with severe preeclampsia
compared with normal pregnant women (P 0.01, Figure 1).
Reverse primer
5=-AGATGGTGATGGGATTTCCATT-3=
5=-CCAACAGTGTAGGTCTTGGTGAAG-3=
5=-CGTTGTCGCAGACGCAGAT-3=
ferentially Methylated in Preeclamptic Omental Arteries
e ID
Mean *
* P valuePE NP
295 0.078 0.054 0.024 0.02
299 0.536 0.480 0.056 0.03
310 0.202 0.154 0.047 0.02
312 0.736 0.816 0.080 0.02
317 0.807 0.882 0.075 0.03
321 0.683 0.740 0.057 0.01
322 0.745 0.830 0.085 0.01
325 0.025 0.014 0.011 0.02
856 0.411 0.543 0.132 0.02
547 0.762 0.862 0.100 0.02
066 0.769 0.726 0.043 0.04
078 0.437 0.338 0.098 0.02
ylation, and  indicates the difference in methylation. Negative values3=ntly Dif
Gen
1
1
1
4
4
4
4
4
118
56
64
7
ll meth
rteries compared with NP arteries.
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AJP October 2012, Vol. 181, No. 10Methylation at the same site was not significantly different in
arteries fromwomen with mild preeclampsia compared with
arteries from normal pregnant women.
The IHC staining revealed increased expression of
MMP-8 in omental and s.c. blood vessels of preeclamptic
women compared with normal pregnant women (Figure 2,
A–D), similar to what we previously showed for MMP-1.6
MMP-8 was mainly expressed in infiltrating neutrophils,
as evidenced by similarity of staining for CD66b in serial
sections, although diffuse staining was also observed in
the vessels. Scoring for MMP-8 staining intensity was
significantly higher in preeclamptic women compared
with normal pregnant women (2.8 0.1 versus 1.2 0.2;
P  0.001; Figure 3A), as was the density of staining for
MMP-8 (121.6 5.2 versus 66.1 7.0; P 0.001; Figure
3B). Staining intensity scores and optical density of stain-
ing were highly correlated (r  0.99). The percentage of
vessels with neutrophils stained for MMP-8 was signifi-
cantly higher in preeclamptic women compared with nor-
mal pregnant women (87.8%  1.5% versus 54.0% 
7.2%; P  0.001; Figure 3C). The percentage of vessels
with diffuse staining for MMP-8 was also significantly
higher in preeclamptic women compared with normal
pregnant women (79.8%  5.7% versus 38.4%  6.1%;
P  0.001; Figure 3D).
To determine whether DNA methylation could be in-
volved in the regulation of MMP1 gene expression in
VSMCs, 5-Aza was used to induce DNA hypomethylation
in the cultured cells. Treatment with 5-Aza provoked a
NP 1 NP 2 NP 3 NP 4 NP 5 NP 6 NP 7 NP 8 NP 9
0
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Figure 1. Bisulfite sequencing of the 1538 site in the MMP1 promoter
region in omental arteries from normal pregnant (NP), mild preeclamptic
(MPE), and severe preeclamptic (SPE) women. Methylation of the 1538 site
is significantly reduced in omental arteries from SPE women (P  0.01), but
not significantly different in omental arteries form MPE women compared
with NP women.significant increase inMMP1 gene expression comparedwith control cells (5.0  0.6-fold, P  0.001, Figure 4A).
To confirm that increased MMP1 gene expression was
associated with an increase in protein production, ELISA
was used to quantify MMP-1 secretion into the media.
Treatment with 5-Aza significantly increased the produc-
tion of MMP-1 protein (3.4  0.3 versus 1.2  0.3 ng/g
DNA; P  0.01; Figure 4B). In contrast to MMP-1, 5-Aza
treatment caused no significant change in gene expres-
sion of TIMP1 or COLIA1 in cultured VSMCs (Figure 5A)
and did not affect protein levels of TIMP-1 in the media
(Figure 5B) or COLIA1 content in cells (Figure 5C).
Figure 2. Representative sections of blood vessels in omental fat from
normal pregnant (NP) and preeclamptic (PE) women immunostained for
MMP-8 (A–C) and CD66b (D). Results for s.c. fat are similar. A: There is no
brown staining for MMP-8 in negative control sections. B: Blood vessels of
normal pregnant women show little or no staining for MMP-8. C and D:
Vessels of preeclamptic women show significant brown staining for MMP-8
(C) and CD66b (D). Staining for MMP-8 in preeclamptic blood vessels is
observed in neutrophils, which are in the lumen, adherent to the endothe-
lium or infiltrated into the wall of the vessel. Diffused staining for MMP-8 is
also present in the vessel wall. A, adipocyte; VL, vessel lumen. The magni-
fication and scale bar are shown on each image.
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Figure 3. Quantitation of IHC staining for MMP-8 in omental and s.c. blood
vessels from normal pregnant (NP; n  5) and preeclamptic (PE; n  5)
women. A: The staining intensity score for MMP-8 is significantly higher in
blood vessels of preeclamptic women compared with normal pregnant
women. B: The OD of staining for MMP-8 is significantly higher in pre-
eclamptic blood vessels. C and D: Preeclamptic women have a significantly
higher percentage of blood vessels with neutrophils stained for MMP-8 and
diffuse staining for MMP-8 compared with normal pregnant women. Data are
presented as mean  SEM. ***P  0.001.
1460 Mousa et al
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sion of MMP-1 was also examined in a neutrophil-like cell
line, HL-60 cells. The expression of MMP-1 in untreated
HL-60 cells was low, but treatment with 5-Aza resulted in
a significant increase in MMP1 gene expression com-
pared with controls (62.4  6.8-fold, P  0.001). PMA
treatment also resulted in a significant increase in MMP1
gene expression (19.6  3.2-fold, P  0.001). Treatment
with PMA caused activation of the cells, as evidenced by
cell adhesion to the culture flask surface. Combined
treatment with 5-Aza and PMA resulted in a dramatic
increase in MMP1 gene expression compared with con-
trols (2622  167-fold, P  0.001), PMA alone (P 
0.001), or 5-Aza alone (P  0.001) (Figure 6A). The gene
expression profiles resulting from 5-Aza treatments cor-
related with protein expression, as indicated by using
Western blot analysis (Figure 6, B and C). Treatment with
5-Aza significantly increased MMP-1 protein expression
(164%  6% average density measurement of the West-
ern blot compared with control, P  0.001). PMA alone
caused no significant change in MMP-1 protein expres-
sion compared with controls. However, combining 5-Aza
with PMA significantly increased MMP-1 protein expres-
sion (261%  6% of control, P  0.001), PMA alone (P 
0.001), or 5-Aza alone (P  0.001).
The role of DNA methylation in the expression of
MMP-8 was also examined in the neutrophil-like cell line.
Treatment with 5-Aza caused a significant increase in
MMP8 gene expression compared with the control (3.2
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Figure 4. MMP-1 expression in cultured human VSMCs treated with 5-Aza
for 48 hours. A: Fold change in gene expression for MMP1 is significantly
increased in treated cultured VSMCs compared with controls (P 0.001, n
8). B: Levels of MMP-1 protein in media are significantly increased in treated
cells compared with controls (P  0.01, n  4). Data are shown as mean 
SEM. **P  0.01, ***P  0.001.0.2-fold, P  0.001). In contrast to MMP1, PMA treatmentdown-regulated MMP8 gene expression, whereas com-
bined treatment of PMA and 5-Aza partially restored
MMP8 gene expression (Figure 7A). The changes in
gene expression were associated with alterations in pro-
tein production, as confirmed by using Western blot anal-
ysis (Figure 7, B and C).
Discussion
In our previous study,6 we demonstrated an imbalance in
collagen-regulating genes, with increased expression of
MMP-1 in VSMCs and infiltrating neutrophils of omental
arteries of preeclamptic women. In this study, we ex-
plored the possible contributions of epigenetic regulation
to this imbalance. We found that the promoter regions of
the MMP1 and MMP8 genes had significantly reduced
methylation in preeclamptic omental arteries compared
with normal pregnant arteries, but there was no signifi-
cant difference in the methylation status for TIMP1 or
COLIA1. In a global assessment of methylation status for
these gene families, we found reduced methylation in
several of the MMP genes, whereas increased methyl-
ation, or no significant change, was present for TIMP and
Figure 5. TIMP-1 and COLIA1 expression in cultured human VSMCs treated
with 5-Aza for 48 hours. A: The fold change in the expression for TIMP1 and
COLIA1 is not significantly changed by 5-Aza treatment compared with
control (n  8). B: TIMP-1 protein levels in media are not significantly
changed compared with controls (n  4). C: Western blot analysis for
pro-COLIA1, and COLIA1 demonstrates no effect of 5-Aza treatment on the
protein expression of COLIA1 (n  3). Data are shown as mean  SEM.
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DNA methylation and others are not is not known, but it
may have to do with their location. Five of the hypomethy-
lated MMP genes in our study were located on chromo-
some 11, with four of them at the same position at
11q22.3. Perhaps certain areas of the chromosome are
more susceptible to factors that can affect DNA methyl-
ation, such as oxidative stress.
In addition to global methylation assessment, we also
examined a specific site (1538) in the MMP1 promoter
that we previously showed was hypomethylated in the
amnion of pregnancies complicated by preterm prema-
ture rupture of membranes.9 DNA sequencing of that site
demonstrated that it was significantly less methylated in
omental arteries of women with severe preeclampsia, but
not those with mild preeclampsia, compared with normal
pregnant women. This may suggest a relationship be-
tween the severity of the preeclampsia and decreased
DNAmethylation. These studies demonstrate that, in both
preterm premature rupture of membranes and pre-
eclampsia, reduced DNA methylation is associated with
increased expression of MMP-1 in tissues, specific to
Figure 6. MMP-1 expression in HL-60 cells treated with 5-Aza for 48 hours,
PMA for 24 hours, or 5-Aza for 48 hours, and then with PMA for 24 hours. A:
The expression of the MMP1 gene is significantly increased in treated cells
compared with control cells. Treatment with PMA after 5-Aza causes a
remarkable increase in MMP1 gene expression compared with control, PMA
alone, or 5-Aza alone (n  8). P  0.001 between all groups. Western blot
analysis (B) and density measurements (C) of the Western blot showing
treatment with 5-Aza significantly increased the expression of MMP-1 protein
in HL-60 cells compared with control. Activation with PMA after treatment
with 5-Aza results in a greater increase in MMP-1 expression compared with
control, 5-Aza alone, or PMA alone (n  4). Data are shown as mean  SEM.
***P  0.001.their pathological features.Similar to the increased expression of MMP-1 we previ-
ously reported,6 the expression of MMP-8 was also in-
creased in omental and s.c. blood vessels of preeclamptic
women compared with normal pregnant women. MMP-8
was mainly expressed in neutrophils, but diffuse staining for
MMP-8 was also present in the vessels, which likely repre-
sents MMP-8 secreted by the neutrophils.
Although our study was designed as an association
study between DNA methylation and gene expression,
enzyme activity is an important consideration. There is
considerable evidence that increased levels of MMP-1
and MMP-8 in preeclamptic women represent active en-
zymes. We previously demonstrated active MMP-1 in ly-
sates of omental arteries of preeclamptic women, but not
normal pregnant women.6 In this study, diffuse staining of
Figure 7. MMP-8 expression in HL-60 cells treated with 5-Aza for 48 hours,
PMA for 24 hours, or 5-Aza for 48 hours and then with PMA for 24 hours. A:
The fold change in the expression for MMP8 is significantly increased in
5-Aza–treated cells compared with control. PMA down-regulates MMP8 ex-
pression, but 5-Aza partially restores it (n 8). Western blot analysis (B) and
density measurements (C) of the Western blot showing 5-Aza significantly
increases the expression of MMP-8. PMA down-regulates MMP-8 expression,
but 5-Aza restores it (n  5). More than one mol. wt. band is present for
MMP-8 because it has multiple glycosylation sites. Data are shown as
mean  SEM. *P  0.05.
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represents active MMP-8 because reactive oxygen spe-
cies released by activated neutrophils mediate conver-
sion of pro-MMP-8 to the active form.14,15 We also previ-
ously reported that plasma of preeclamptic women
contains significant amounts of active MMP-1, whereas
plasma of normal pregnant women does not.6 Activation
of MMPs is most likely related to the oxidative stress of
preeclampsia16,17 and the release of reactive oxygen
species by infiltrating neutrophils because reactive oxy-
gen species are known activators of MMPs.14,15,18–20
To study the role of DNA methylation in the regulation
of these genes in vascular tissue, we experimentally in-
duced DNA hypomethylation in cultured human VSMCs.
Hypomethylation resulted in a significant increase in
MMP-1 expression but did not significantly affect TIMP-1
or COLIA1, which is similar to our findings for omental
arteries of preeclamptic women.6 TIMP and COL genes
are apparently regulated by mechanisms other than DNA
methylation. Allelic variations in the COLIA1 gene have
been associated with preeclampsia,21 which may explain
its reduced expression in omental arteries of preeclamp-
tic women.6
We also examined the effect of hypomethylation on
MMP-1 and MMP-8 expression in a neutrophil cell line be-
cause neutrophils infiltrate maternal systemic blood vessels
in preeclampsia and strongly express these MMPs. We
found that DNA hypomethylation significantly increased
both MMP-1 and MMP-8 expression in HL-60 cells.
Stimulation of HL-60 cells with PMA, a classic inducer
of leukocyte activation, resulted in a significant increase
in MMP-1, but not MMP-8, suggesting that MMP-1 and
MMP-8 are differentially regulated in these cells. This is
supported by the fact that when DNA hypomethylation
was combined with PMA, there was a dramatic increase
in the expression of MMP-1, but not MMP-8. On the other
hand, results from 5-Aza treatment suggest that de-
creased DNA methylation in neutrophils contributes to
the increased expression of both MMP-1 and MMP-8 in
maternal systemic blood vessels of preeclamptic women
by increasing the capacity of infiltrating neutrophils to
produce these MMPs. A global decrease in DNA meth-
ylation in leukocytes was reported in other diseases in-
volving the cardiovascular system, including atheroscle-
rosis,22 ischemic heart disease, and stroke.23 Untreated
HL-60 cells showed low expression of MMP-1, which is
similar to unactivated neutrophils. This suggests that
MMP-1 expression in unactivated cells is largely silenced
by DNA methylation, and that reduced DNA methylation
contributes to increased expression of MMP-1 in infiltrat-
ing neutrophils in preeclamptic women.
The imbalance in collagen-regulating proteins in pre-
eclamptic vessels suggests increased collagenolytic ac-
tivity, which could contribute to the development of
edema and proteinuria by compromising the structural
integrity of the vessels and increasing their permeability
to blood proteins.
Increased expression of MMP-1 may contribute to the
pathophysiological characteristics of preeclampsia in an-
other, and unexpected, way. We found that activated
MMP-1 is a potent vasoconstrictor acting via protease-activated receptor-1, which is overexpressed in omental
arteries of preeclamptic women.6 We subsequently
showed that activation of protease-activated receptor-1
resulted in release of endothelial endothelin-1, which me-
diated the vasoconstrictor effects of MMP-1.24 Important
to this finding was that plasma levels of activated MMP-1
in preeclamptic women were within the dose-response
range for vasoconstriction, whereas levels in normal
pregnant women were not. Therefore, increased MMP-1
levels in blood vessels and plasma of preeclamptic
women may play an important, but previously unrecog-
nized, role in regulating vascular tone. It may seem coun-
terintuitive that vessels with less collagen should have an
increase in tone, but the function of collagen as a struc-
tural protein to maintain vessel integrity is independent of
the function of vascular smooth muscle to control vessel
tone. Because collagen is not a contractile protein, and
imparts stiffness to vessels, the vessels may contract
more extensively with less collagen present. Other inves-
tigators have shown that MMP-2 can cause vasoconstric-
tion by activating vasoconstrictor peptides.25–27
Our study has several limitations in that our findings
are correlative and do not prove a cause-and-effect re-
lationship between reduced methylation and increased
expression of MMP-1 and MMP-8. We also cannot prove
that reduced methylation of the MMP1 or MMP8 gene
promoters per se was responsible for increased expres-
sion, because methylation changes may have indirectly
altered gene expression (eg, resulting in increased expres-
sion of critical transcription factors). In addition, we were not
able to determine the cell types in which methylation
changes were occurring in the omental arteries because of
the cellular heterogeneity, which includes endothelial cells,
VSMCs, and infiltrated neutrophils. However, by experimen-
tally inducing hypomethylation in VSMCs and a neutrophil-
like cell line, we were able to document that reduced meth-
ylation is strongly associated with increased expression of
MMPs in both cell types.
In summary, we have shown that the promoter regions
of theMMP1 andMMP8 genes have reduced methylation
in omental arteries of preeclamptic women compared
with those of normal pregnant women, whereas the pro-
moter regions of the TIMP and COL genes tend to be
more methylated or unchanged. By experimentally induc-
ing DNA hypomethylation in cultured human VSMCs and
a neutrophil-like cell line, we were able to mimic the
imbalance in collagen-regulating genes present in sys-
temic blood vessels of preeclamptic women. These find-
ings suggest the possibility that epigenetic mechanisms
directly involving the promoters of the target collagen
metabolism genes, or possibly genes that regulate their
expression (eg, transcription factors), play an important
role in the vascular dysfunction associated with pre-
eclampsia.
Our study may have clinical implications for the treat-
ment or prevention of preeclampsia based on restoring
methylation. Folate is an essential component in the fo-
late-methionine cycle that synthesizes methyl donors
used by methyltransferases to methylate DNA. Therefore,
dietary supplementation with folate might restore re-
duced methylation in MMP genes and protect against the
Collagen Metabolism in Preeclampsia 1463
AJP October 2012, Vol. 181, No. 10development of preeclampsia. Consistent with this notion
is a recent large study composed of almost 3000 preg-
nant women, which found supplementation with multivi-
tamins containing folic acid was associated with a re-
duced risk of preeclampsia.28
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